TOCOLYTIC DRUGS FOR WOMEN IN PRETERM LABOUR
TOCOLYTIC DRUGS FOR WOMEN IN PRETERM LABOUR
复制标题
用于早产妇女的宫缩药物
DOI：
--
复制
发表时间：
2003
期刊：
影响因子：
--
通讯作者：
B. Hamkalo
中科院分区：
文献类型：
--
作者：
J. Rattner;B. Hamkalo
早产是影响婴儿存活率和生活质量的最重要因素。虽然早产被定义为在37周之前，但大多数死亡率和发病率是在34周之前出生的婴儿。预防和治疗早产很重要，但其本身不是目的，而是减少对儿童不利事件的一种手段。对于许多早产的妇女来说，考虑尝试安胎可能是不合适的。例如，分娩可能过于提前，或者由于宫内感染或胎盘排斥，延长妊娠可能是危险的。由于接受干预的是妇女，因此也有责任确保她不受伤害。
Preterm birth is the most important single determinant of adverse infant outcome, in terms of both survival and quality of life. Although preterm birth is defined as being before 37 completed weeks, most mortality and morbidity is experienced by babies born before 34 weeks. Prevention and treatment of preterm labour is important, not as an end in itself, but as a means of reducing adverse events for the child. For many women in preterm labour it may not be appropriate to consider attempting tocolysis. Labour may be too advanced, for example, or prolonging the pregnancy may be hazardous because of intrauterine infection or placental abruption. As it is the woman who receives the intervention, there is also a responsibility to ensure that she is not harmed.